
Keywords: گلوکاگون مانند پپتید; BMI; Body Mass Index; mTOR; Mechanistic target of Rapamycin; NOD; New onset diabetes; HbA1c; Hemoglobin A1c; ADT; Androgen Deprivation Therapy; GLP-1; Glucagon Like peptide; CVD; Cardiovascular disease; HIV; Human Immunodeficiency Virus; LDL; Low density